Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Cidara Therapeutics (CDTX) Leases: 2019-2025

Historic Leases for Cidara Therapeutics (CDTX) over the last 7 years, with Sep 2025 value amounting to $1.8 million.

  • Cidara Therapeutics' Leases fell 40.86% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 40.86%. This contributed to the annual value of $2.7 million for FY2024, which is 27.69% down from last year.
  • Cidara Therapeutics' Leases amounted to $1.8 million in Q3 2025, which was down 15.33% from $2.1 million recorded in Q2 2025.
  • Cidara Therapeutics' 5-year Leases high stood at $4.3 million for Q2 2023, and its period low was $446,000 during Q2 2021.
  • In the last 3 years, Cidara Therapeutics' Leases had a median value of $3.0 million in 2024 and averaged $2.9 million.
  • As far as peak fluctuations go, Cidara Therapeutics' Leases tumbled by 64.52% in 2021, and later surged by 330.50% in 2024.
  • Over the past 5 years, Cidara Therapeutics' Leases (Quarterly) stood at $2.3 million in 2021, then crashed by 51.95% to $1.1 million in 2022, then spiked by 244.68% to $3.8 million in 2023, then fell by 27.69% to $2.7 million in 2024, then tumbled by 40.86% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, $2.1 million for Q2 2025, and $2.4 million during Q1 2025.